|
1.
Rauch F, Glorieux FH. Osteogenesis Imperfecta. Lancet.
2004;363:1377-85.
https://doi.org/10.1016/S0140-6736(04)16051-0
|
|
|
|
2. Glorieux FH, Bishop
NJ, Plotkin H, Chabot G, Lanoue G, Travers R.
Cyclic administration of pamidronate in children
with severe osteogenesis imperfecta. N
Engl J Med. 1998;339:947-52.
https://doi.org/10.1056/NEJM199810013391402
PMid:9753709
|
|
|
|
|
3. Assael LA. Oral
bisphosphonates as a cause of bisphosphonate-
related osteonecrosis of the jaws: Clinical
findings, assessment of risks, and preventive
strategies. J Oral
Maxillofac Surg. 2009;67:35-43.
https://doi.org/10.1016/j.joms.2009.01.003
PMid:19371813
|
|
|
|
|
4. Ruggiero SL, Fantasia
J, Carlson E. Bisphosphonate-related
osteonecrosis of the jaw: background and guidelines
for diagnosis, staging and management. Oral Surg
Oral Med Oral Pathol Oral Radiol Endod.
2006;102:433-41.
https://doi.org/10.1016/j.tripleo.2006.06.004
PMid:16997108
|
|
|
|
|
5. Ruggiero SL, Dodson
TB, Assael LA, Landesberg R, Marx RE, Mehrotra B;
American Association of Oral and Maxillofacial
Surgeons. American Association of Oral and Maxillofacial
Surgeons position paper on bisphosphonate-related
osteonecrosis of the jaws--2009
update. J Oral Maxillofac Surg. 2009;67:2-12.
PMid:19371809
|
|
|
|
|
6. Wang EP, Kaban LB,
Incidence of osteonecrosis of the jaw in patients
with multiple myeloma and breast or prostate
cancer on intravenous Bisphosphonate therapy. J
Oral Maxillofac Surg. 2007;65:1328-31.
https://doi.org/10.1016/j.joms.2007.03.006
PMid:17577497
|
|
|
|
|
7. Friberg B. Brånemark
system implants and rare disorders: a report of
six cases. Int J Periodontics Restorative Dent.
2013;33:139-48.
https://doi.org/10.11607/prd.1429
PMid:23484169
|
|
|
|
|
8. Payne M, Smith D.
Implant-supported rehabilitation of an edentate
patient with Osteogénesis Imperfecta. A
case report. Int J Oral Maxillofac Implants.
2008;23:947-52.
PMid:19014167
|
|
|
|
|
9. Alghamdi H, Anand PS,
Anil S. Undersized implant site preparation to
enhance primary implant stability in poor bone
density: a prospective clinical study. J
Oral Maxillofac Surg. 2011;69:e506-12.
https://doi.org/10.1016/j.joms.2011.08.007
PMid:22117707
|
|
|
|
|
10.
Farré-Pagés N, Augé-Castro ML, Alaejos-Algarra F,
Mareque-Bueno J, Ferrés-Padró E, Hernández-Alfaro
F. Relation between bone density and primary
implant stability. Med Oral Patol Oral Cir Bucal.
2011;16:e62-7.
https://doi.org/10.4317/medoral.16.e62
PMid:20711163
|
|
|
|
|
11. Lee CY, Ertel SK.
Bone graft augmentation and dental implant
treatment in a patient with osteogenesis
imperfecta: review of the literature with a case
report. Implant
Dent. 2003;12:291-5.
https://doi.org/10.1097/01.ID.0000086481.84152.42
|
|
|
|
|
12. Binger T, Rücker M,
Spitzer WJ. Dentofacial rehabilitation by
osteodistraction, augmentation and implantation
despite osteogenesis imperfecta. Int J Oral
Maxillofac Surg. 2006;35:559-62.
https://doi.org/10.1016/j.ijom.2006.01.014
PMid:16520021
|
|
|
|
|
13. Prabhu N, Duckmanton
N, Stevenson AR, Cameron A. The placement of
osseointegrated dental implants in a patient with
type IV B osteogenesis imperfecta: a 9-year
follow-up. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod. 2007;103:349-54.
https://doi.org/10.1016/j.tripleo.2006.06.006
PMid:17321445
|
|
|
|
|
14. Wannfors K,
Johansson C, Donath K. Augmentation of the
mandible via a "tent-pole" procedure
and implant treatment in a patient with type III
osteogenesis imperfecta: clinical and histologic
considerations. Int
J Oral Maxillofac Implants. 2009;24:1144-8.
PMid:20162121
|
|
|
|
|
15. Marx RE. A decade of
bisphosphonate bone complications: what it has
taught us about bone physiology. Int J Oral
Maxillofac Implants. 2014;29:e247-58.
https://doi.org/10.11607/jomi.te61
PMid:24683588
|
|